Biocryst Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Biocryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Frequently asked questions
To buy Biocryst Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Biocryst Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Biocryst Pharmaceuticals Inc. is BCRX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Biocryst Pharmaceuticals Inc. has its primary listing on NASDAQ. You can trade Biocryst Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Biocryst Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Biocryst Pharmaceuticals Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Biocryst Pharmaceuticals Inc..